Johnson and Johnson Pinnacle hip trials. According to the latest court order issued on August 25, the latest round of Johnson and Johnson DePuy Pinnacle hip failure trials are set to start in early September.
Johnson and Johnson, the world’s largest pharmaceutical company and medical device maker, and its DePuy subsidiary are under fire over similar allegations involving its Pinnacle/Ultamet line of metal hip devices which are prone to metal poisoning and premature failure according to lawsuits.
Despite vigorous objections by Johnson and Johnson to remand the selected bellwether cases and the over 9,000 claimants back to their individual U.S. District Courts nationwide for trial dates, the judge overseeing the DePuy Pinnacle hip implant multidistrict litigation has designated eight cases as the final bellwether cases tried in the Dallas Division in the Northern District of Texas.
Johnson and Johnson Pinnacle hip trials
In May 2011, the U.S. Judicial Panel on Multidistrict Litigation centralized pretrial proceedings in the cases before Judge Kinkeade in the in the U.S. District Court for the Northern District of Texas, as part of an MDL, or multidistrict litigation.
The Texas federal court has more than 9,000 hip implant lawsuits, involving the Johnson and Johnson DePuy Orthopaedics’ Pinnacle Hip Replacement system that uses the metal Ultamet liner.
Johnson and Johnson Pinnacle hip trials: No Settlements
There have been no settlements to date over the Johnson and Johnson DePuy Orthopaedics’ Pinnacle Hip Replacement system, and Johnson & Johnson has vowed that it has no intention of settling hip replacement injury claims for patients who have developed serious and catastrophic injuries from the DePuy Pinnacle implants.
What is the problem with the DePuy Pinnacle hip system?
Over the past several years medical studies have found that some all-metal implants can release dangerous amounts of toxic cobalt and chromium metal ions particles locally into the hip joint and the blood stream, causing severe local tissue reactions and premature failure complications that require painful revision surgery to remove and replace the implant. This metallic debris causes the medical condition known as metallosis.
Why won’t DePuy announce a recall over its Pinnacle/Ultamet liner system?
This is not the first ride at the rodeo for Johnson and Johnson and its subsidiary DePuy, the makers of the Pinnacle/Ultamet liner system.
DePuy announced a global hip replacement recall for its ASR line of metal implants in August 2010, after worldwide reports of metallosis and premature hip failure. Johnson & Johnson in 2013 had agreed to pay at least $2.5 billion to settle more than 9,000 lawsuits over DePuy ASR hip replacements, which feature a metal-on-metal design that has been described as a “substantial equivalent” to the Pinnacle hip
Since the premature failure and metal toxicity rates are similar between the two implant designs, many folks now question why the company has not taken similar action in regards to the Pinnacle/Ultamet liner combination. Cynics point to the billions of dollars that Johnson and Johnson have made in profits from the DePuy Pinnacle line of implants as being the motivating factor.
Johnson and Johnson Pinnacle hip trials
The first Texas DePuy Pinnacle Metal Hip Trial in 2014 ended with a win for the defense.
In the second Texas DePuy Pinnacle Metal Hip Trial in 2016, the five plaintiffs were awarded a total of $500 million. The jury award was reduced to $151 million, in order to comply with Texas law governing punitive damages.
In the third bellwether trial in 2017 the six damaged Pinnacle patients were awarded more than $1 billion. That judgment was later reduced to $543 million.
Injured by a failed DePuy Pinnacle Metal Hip?
If you think you may have a DePuy Pinnacle Metal Hip and are experiencing pain caused by metal corrosion or have suffered a hip failure requiring full revision and emergency care, please call Dr. Shezad Malik Law Firm at 214-390-3189.